Yong-Moon Park
Concepts (390)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 48 | 2026 | 591 | 6.510 |
Why?
| | Obesity | 40 | 2026 | 1204 | 5.400 |
Why?
| | Republic of Korea | 73 | 2026 | 97 | 4.710 |
Why?
| | Breast Neoplasms | 18 | 2026 | 1222 | 4.520 |
Why?
| | Nutrition Surveys | 38 | 2023 | 118 | 4.140 |
Why?
| | Diet, Mediterranean | 8 | 2023 | 10 | 3.820 |
Why?
| | Risk Factors | 91 | 2026 | 4017 | 3.290 |
Why?
| | Cardiovascular Diseases | 20 | 2025 | 501 | 3.030 |
Why?
| | Insulin Resistance | 17 | 2018 | 282 | 3.010 |
Why?
| | Hypertension | 19 | 2025 | 554 | 2.860 |
Why?
| | Blood Glucose | 25 | 2025 | 490 | 2.800 |
Why?
| | Body Mass Index | 38 | 2025 | 717 | 2.550 |
Why?
| | Middle Aged | 122 | 2026 | 13419 | 2.500 |
Why?
| | Female | 144 | 2026 | 28782 | 2.190 |
Why?
| | Adult | 108 | 2026 | 14534 | 2.120 |
Why?
| | Aged | 92 | 2026 | 10429 | 2.000 |
Why?
| | Humans | 166 | 2026 | 53230 | 1.830 |
Why?
| | Diabetes Mellitus | 12 | 2025 | 321 | 1.730 |
Why?
| | Diet | 11 | 2023 | 610 | 1.720 |
Why?
| | Proportional Hazards Models | 25 | 2026 | 445 | 1.500 |
Why?
| | Triglycerides | 12 | 2020 | 171 | 1.500 |
Why?
| | Overweight | 8 | 2019 | 232 | 1.490 |
Why?
| | Male | 111 | 2025 | 27435 | 1.480 |
Why?
| | Postmenopause | 9 | 2026 | 85 | 1.450 |
Why?
| | Prospective Studies | 29 | 2023 | 2411 | 1.440 |
Why?
| | Metformin | 4 | 2021 | 84 | 1.430 |
Why?
| | Inflammation | 4 | 2022 | 652 | 1.410 |
Why?
| | Health Surveys | 9 | 2020 | 248 | 1.330 |
Why?
| | Cohort Studies | 38 | 2026 | 1557 | 1.320 |
Why?
| | Siblings | 3 | 2021 | 35 | 1.290 |
Why?
| | Incidence | 29 | 2025 | 1085 | 1.260 |
Why?
| | Blood Pressure | 14 | 2025 | 518 | 1.240 |
Why?
| | Cross-Sectional Studies | 24 | 2023 | 1723 | 1.220 |
Why?
| | Periodontitis | 6 | 2021 | 11 | 1.180 |
Why?
| | Exercise | 7 | 2024 | 561 | 1.170 |
Why?
| | Prevalence | 25 | 2025 | 1034 | 1.140 |
Why?
| | F2-Isoprostanes | 4 | 2023 | 8 | 1.110 |
Why?
| | Dementia | 3 | 2026 | 141 | 1.110 |
Why?
| | Hypoglycemia | 8 | 2022 | 62 | 1.110 |
Why?
| | Income | 3 | 2024 | 106 | 1.020 |
Why?
| | Neoplasms | 7 | 2025 | 1334 | 0.990 |
Why?
| | Aging | 6 | 2022 | 714 | 0.980 |
Why?
| | Feeding Behavior | 5 | 2022 | 195 | 0.960 |
Why?
| | Waist Circumference | 11 | 2020 | 23 | 0.920 |
Why?
| | Oxidative Stress | 5 | 2023 | 819 | 0.890 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2025 | 47 | 0.870 |
Why?
| | Follow-Up Studies | 26 | 2025 | 2318 | 0.860 |
Why?
| | Mammography | 1 | 2025 | 99 | 0.850 |
Why?
| | Circadian Rhythm | 1 | 2024 | 91 | 0.840 |
Why?
| | Diabetic Retinopathy | 6 | 2016 | 50 | 0.840 |
Why?
| | Stroke | 10 | 2024 | 520 | 0.830 |
Why?
| | Esophageal Neoplasms | 2 | 2022 | 113 | 0.830 |
Why?
| | Cataract | 2 | 2015 | 44 | 0.820 |
Why?
| | Young Adult | 22 | 2024 | 4511 | 0.810 |
Why?
| | Atrial Fibrillation | 2 | 2024 | 197 | 0.810 |
Why?
| | Premenopause | 9 | 2026 | 28 | 0.780 |
Why?
| | Body Weight | 6 | 2019 | 524 | 0.780 |
Why?
| | Aged, 80 and over | 18 | 2024 | 3494 | 0.770 |
Why?
| | Diabetes, Gestational | 3 | 2022 | 52 | 0.760 |
Why?
| | Diabetic Angiopathies | 5 | 2018 | 23 | 0.760 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2014 | 182 | 0.750 |
Why?
| | Isoprostanes | 1 | 2022 | 2 | 0.740 |
Why?
| | Cholesterol | 8 | 2021 | 161 | 0.720 |
Why?
| | United States | 20 | 2023 | 5409 | 0.710 |
Why?
| | Risk Assessment | 5 | 2019 | 1368 | 0.680 |
Why?
| | Age Factors | 8 | 2020 | 1136 | 0.670 |
Why?
| | Cholesterol, HDL | 9 | 2021 | 38 | 0.670 |
Why?
| | Glaucoma, Open-Angle | 2 | 2020 | 26 | 0.660 |
Why?
| | Coronary Artery Disease | 4 | 2025 | 324 | 0.650 |
Why?
| | Intraocular Pressure | 4 | 2020 | 65 | 0.620 |
Why?
| | Odds Ratio | 9 | 2018 | 567 | 0.620 |
Why?
| | Phenotype | 8 | 2026 | 803 | 0.620 |
Why?
| | Insulin | 8 | 2018 | 493 | 0.610 |
Why?
| | Retrospective Studies | 21 | 2026 | 6819 | 0.610 |
Why?
| | Menopause | 2 | 2026 | 41 | 0.610 |
Why?
| | Myocardial Infarction | 6 | 2024 | 445 | 0.600 |
Why?
| | Cause of Death | 7 | 2025 | 156 | 0.580 |
Why?
| | Metabolic Diseases | 3 | 2017 | 47 | 0.580 |
Why?
| | Adenocarcinoma | 1 | 2022 | 405 | 0.580 |
Why?
| | Acidosis | 1 | 2018 | 37 | 0.580 |
Why?
| | Fasting | 6 | 2020 | 76 | 0.560 |
Why?
| | Physical Fitness | 2 | 2015 | 56 | 0.550 |
Why?
| | Hypoglycemic Agents | 6 | 2021 | 227 | 0.550 |
Why?
| | Plaque, Atherosclerotic | 1 | 2018 | 45 | 0.540 |
Why?
| | Diabetic Neuropathies | 5 | 2018 | 57 | 0.530 |
Why?
| | Hypertriglyceridemia | 2 | 2014 | 18 | 0.510 |
Why?
| | Glucose Intolerance | 3 | 2025 | 27 | 0.510 |
Why?
| | Alanine Transaminase | 2 | 2014 | 118 | 0.500 |
Why?
| | Prognosis | 15 | 2024 | 2118 | 0.500 |
Why?
| | Breast Feeding | 1 | 2018 | 203 | 0.500 |
Why?
| | Sex Factors | 10 | 2017 | 747 | 0.490 |
Why?
| | Obesity, Abdominal | 5 | 2023 | 20 | 0.470 |
Why?
| | Sleep | 4 | 2024 | 195 | 0.470 |
Why?
| | Colorectal Neoplasms | 4 | 2024 | 302 | 0.460 |
Why?
| | Nutrition Assessment | 4 | 2021 | 67 | 0.460 |
Why?
| | Ideal Body Weight | 1 | 2015 | 6 | 0.460 |
Why?
| | Muscles | 1 | 2015 | 110 | 0.450 |
Why?
| | Lipids | 2 | 2015 | 163 | 0.450 |
Why?
| | Diabetes Complications | 2 | 2015 | 124 | 0.450 |
Why?
| | Lipoproteins | 1 | 2015 | 41 | 0.450 |
Why?
| | Kidney Failure, Chronic | 3 | 2025 | 210 | 0.450 |
Why?
| | Antihypertensive Agents | 3 | 2016 | 130 | 0.440 |
Why?
| | Zinc | 1 | 2015 | 56 | 0.440 |
Why?
| | Autonomic Nervous System | 4 | 2018 | 60 | 0.440 |
Why?
| | Energy Metabolism | 1 | 2017 | 324 | 0.430 |
Why?
| | Time Factors | 11 | 2026 | 2991 | 0.420 |
Why?
| | Heart Rate | 7 | 2018 | 314 | 0.410 |
Why?
| | Intellectual Disability | 2 | 2024 | 129 | 0.400 |
Why?
| | Body Composition | 1 | 2015 | 355 | 0.390 |
Why?
| | Bipolar Disorder | 1 | 2014 | 201 | 0.380 |
Why?
| | Sarcopenia | 1 | 2014 | 100 | 0.380 |
Why?
| | Depressive Disorder, Major | 1 | 2014 | 149 | 0.380 |
Why?
| | Ferritins | 1 | 2012 | 38 | 0.370 |
Why?
| | Lipoprotein(a) | 3 | 2016 | 6 | 0.370 |
Why?
| | Comorbidity | 5 | 2018 | 638 | 0.360 |
Why?
| | Osteoarthritis, Knee | 2 | 2023 | 97 | 0.360 |
Why?
| | Dinoprost | 3 | 2022 | 6 | 0.360 |
Why?
| | Socioeconomic Factors | 4 | 2018 | 623 | 0.350 |
Why?
| | Adipose Tissue | 1 | 2013 | 210 | 0.340 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2012 | 523 | 0.340 |
Why?
| | Databases, Factual | 6 | 2024 | 742 | 0.330 |
Why?
| | Percutaneous Coronary Intervention | 2 | 2025 | 329 | 0.330 |
Why?
| | Cardiovascular System | 3 | 2018 | 55 | 0.310 |
Why?
| | Alcohol Drinking | 6 | 2021 | 241 | 0.300 |
Why?
| | Meat | 2 | 2019 | 60 | 0.290 |
Why?
| | Energy Intake | 3 | 2022 | 186 | 0.290 |
Why?
| | Sex Distribution | 5 | 2015 | 140 | 0.290 |
Why?
| | Toothbrushing | 2 | 2021 | 5 | 0.280 |
Why?
| | Case-Control Studies | 6 | 2025 | 1212 | 0.270 |
Why?
| | Renal Insufficiency, Chronic | 3 | 2015 | 205 | 0.270 |
Why?
| | Medicaid | 4 | 2014 | 294 | 0.270 |
Why?
| | National Health Programs | 2 | 2024 | 19 | 0.270 |
Why?
| | Korea | 5 | 2023 | 10 | 0.250 |
Why?
| | Brain Ischemia | 2 | 2018 | 162 | 0.240 |
Why?
| | Rural Population | 6 | 2025 | 596 | 0.230 |
Why?
| | Reproduction | 1 | 2026 | 64 | 0.230 |
Why?
| | Hypercholesterolemia | 2 | 2017 | 40 | 0.230 |
Why?
| | Diabetic Cardiomyopathies | 2 | 2017 | 4 | 0.230 |
Why?
| | ROC Curve | 4 | 2014 | 246 | 0.230 |
Why?
| | Dietary Fats | 2 | 2018 | 133 | 0.230 |
Why?
| | Antibodies, Bacterial | 3 | 2019 | 29 | 0.230 |
Why?
| | Educational Status | 3 | 2015 | 229 | 0.220 |
Why?
| | Time-to-Treatment | 1 | 2026 | 81 | 0.220 |
Why?
| | Weight Gain | 2 | 2025 | 245 | 0.220 |
Why?
| | Vitamin B 12 Deficiency | 2 | 2014 | 9 | 0.220 |
Why?
| | Lighting | 1 | 2024 | 5 | 0.220 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2025 | 106 | 0.220 |
Why?
| | Autonomic Nervous System Diseases | 2 | 2016 | 13 | 0.220 |
Why?
| | Myopia | 2 | 2014 | 9 | 0.220 |
Why?
| | Light | 1 | 2024 | 51 | 0.220 |
Why?
| | Healthcare Disparities | 2 | 2026 | 312 | 0.210 |
Why?
| | Logistic Models | 3 | 2018 | 947 | 0.210 |
Why?
| | Neoplasm Invasiveness | 1 | 2025 | 281 | 0.210 |
Why?
| | Poverty Areas | 1 | 2024 | 52 | 0.210 |
Why?
| | Air Pollutants | 1 | 2025 | 75 | 0.210 |
Why?
| | Sex Characteristics | 3 | 2016 | 204 | 0.210 |
Why?
| | Anthracyclines | 1 | 2024 | 35 | 0.200 |
Why?
| | Up-Regulation | 3 | 2016 | 456 | 0.200 |
Why?
| | Receptors, Estrogen | 2 | 2021 | 134 | 0.200 |
Why?
| | Adolescent | 7 | 2023 | 6907 | 0.200 |
Why?
| | Insurance Coverage | 1 | 2024 | 124 | 0.200 |
Why?
| | Early Detection of Cancer | 1 | 2025 | 190 | 0.190 |
Why?
| | Cooking | 2 | 2019 | 16 | 0.190 |
Why?
| | Risk | 3 | 2019 | 306 | 0.190 |
Why?
| | Health Status | 2 | 2015 | 306 | 0.190 |
Why?
| | Survivors | 1 | 2024 | 120 | 0.190 |
Why?
| | Down-Regulation | 2 | 2015 | 344 | 0.190 |
Why?
| | Environmental Exposure | 1 | 2025 | 222 | 0.190 |
Why?
| | Lutein | 1 | 2022 | 4 | 0.180 |
Why?
| | beta Carotene | 1 | 2022 | 9 | 0.180 |
Why?
| | Carotenoids | 1 | 2022 | 24 | 0.180 |
Why?
| | Health Status Disparities | 1 | 2025 | 221 | 0.180 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2022 | 22 | 0.180 |
Why?
| | Hyperglycemia | 2 | 2019 | 90 | 0.180 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2022 | 70 | 0.180 |
Why?
| | Laryngeal Neoplasms | 1 | 2022 | 44 | 0.180 |
Why?
| | Registries | 4 | 2026 | 652 | 0.180 |
Why?
| | Lung | 1 | 2025 | 481 | 0.170 |
Why?
| | Plant Proteins | 1 | 2022 | 72 | 0.170 |
Why?
| | Tuberculosis | 1 | 2022 | 133 | 0.170 |
Why?
| | Health Services Accessibility | 1 | 2026 | 477 | 0.170 |
Why?
| | Periodontal Index | 3 | 2017 | 6 | 0.170 |
Why?
| | Reference Values | 3 | 2016 | 311 | 0.160 |
Why?
| | Child | 6 | 2018 | 7379 | 0.160 |
Why?
| | Glucose | 2 | 2020 | 361 | 0.160 |
Why?
| | Neoplasm Staging | 2 | 2025 | 774 | 0.160 |
Why?
| | Survival Rate | 3 | 2020 | 949 | 0.160 |
Why?
| | Cardiac Surgical Procedures | 2 | 2013 | 331 | 0.150 |
Why?
| | Anthropometry | 2 | 2017 | 101 | 0.150 |
Why?
| | Waist-Hip Ratio | 2 | 2017 | 9 | 0.150 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2019 | 42 | 0.150 |
Why?
| | Depression | 1 | 2024 | 621 | 0.150 |
Why?
| | Influenza, Human | 1 | 2020 | 88 | 0.150 |
Why?
| | Breakfast | 1 | 2019 | 18 | 0.150 |
Why?
| | Arkansas | 4 | 2026 | 2068 | 0.150 |
Why?
| | Anti-Mullerian Hormone | 1 | 2018 | 4 | 0.150 |
Why?
| | Smoking | 4 | 2017 | 526 | 0.150 |
Why?
| | Albuminuria | 3 | 2016 | 49 | 0.140 |
Why?
| | Smoking Cessation | 1 | 2022 | 325 | 0.140 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2018 | 169 | 0.140 |
Why?
| | Parkinson Disease | 1 | 2021 | 156 | 0.140 |
Why?
| | Diabetic Nephropathies | 2 | 2016 | 61 | 0.140 |
Why?
| | Vegetables | 1 | 2018 | 67 | 0.140 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 412 | 0.140 |
Why?
| | Mouth | 1 | 2018 | 36 | 0.140 |
Why?
| | Glycemic Index | 1 | 2018 | 3 | 0.140 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2020 | 212 | 0.140 |
Why?
| | South Carolina | 2 | 2014 | 21 | 0.140 |
Why?
| | Fruit | 1 | 2018 | 129 | 0.140 |
Why?
| | Cluster Analysis | 1 | 2018 | 237 | 0.130 |
Why?
| | Severity of Illness Index | 5 | 2020 | 1049 | 0.130 |
Why?
| | Dental Caries | 1 | 2017 | 10 | 0.130 |
Why?
| | Heart Defects, Congenital | 2 | 2013 | 625 | 0.130 |
Why?
| | Periodontal Diseases | 1 | 2017 | 12 | 0.130 |
Why?
| | Membrane Transport Modulators | 1 | 2017 | 6 | 0.130 |
Why?
| | Longitudinal Studies | 5 | 2022 | 774 | 0.130 |
Why?
| | Psoriasis | 1 | 2017 | 29 | 0.130 |
Why?
| | Alzheimer Disease | 1 | 2021 | 338 | 0.130 |
Why?
| | Tonometry, Ocular | 1 | 2016 | 8 | 0.130 |
Why?
| | Obesity, Morbid | 1 | 2018 | 86 | 0.130 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2017 | 29 | 0.130 |
Why?
| | Liver Neoplasms | 1 | 2020 | 346 | 0.130 |
Why?
| | Age Distribution | 2 | 2015 | 175 | 0.120 |
Why?
| | Stomach Neoplasms | 1 | 2020 | 207 | 0.120 |
Why?
| | Heart | 2 | 2016 | 350 | 0.120 |
Why?
| | Pregnancy | 3 | 2022 | 2608 | 0.120 |
Why?
| | C-Reactive Protein | 1 | 2016 | 152 | 0.120 |
Why?
| | Predictive Value of Tests | 5 | 2017 | 934 | 0.120 |
Why?
| | Prediabetic State | 1 | 2015 | 22 | 0.120 |
Why?
| | Blepharoptosis | 1 | 2015 | 13 | 0.110 |
Why?
| | Sensitivity and Specificity | 2 | 2015 | 867 | 0.110 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2015 | 107 | 0.110 |
Why?
| | Rural Health | 1 | 2015 | 88 | 0.110 |
Why?
| | Laminectomy | 1 | 2015 | 8 | 0.110 |
Why?
| | Diskectomy | 1 | 2015 | 11 | 0.110 |
Why?
| | Preoperative Period | 1 | 2015 | 47 | 0.110 |
Why?
| | Texas | 1 | 2015 | 138 | 0.110 |
Why?
| | Diabetic Foot | 1 | 2016 | 79 | 0.110 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2014 | 14 | 0.110 |
Why?
| | Patient Compliance | 1 | 2016 | 232 | 0.110 |
Why?
| | beta 2-Microglobulin | 1 | 2014 | 39 | 0.110 |
Why?
| | Conduct Disorder | 1 | 2014 | 10 | 0.110 |
Why?
| | Drug Combinations | 1 | 2014 | 138 | 0.110 |
Why?
| | Social Class | 1 | 2015 | 97 | 0.110 |
Why?
| | Food Supply | 1 | 2015 | 95 | 0.110 |
Why?
| | Glaucoma | 1 | 2014 | 39 | 0.110 |
Why?
| | Forecasting | 1 | 2015 | 152 | 0.110 |
Why?
| | Anesthesia, General | 1 | 2015 | 99 | 0.100 |
Why?
| | Linear Models | 1 | 2015 | 287 | 0.100 |
Why?
| | Health Status Indicators | 1 | 2014 | 80 | 0.100 |
Why?
| | Anxiety Disorders | 1 | 2014 | 133 | 0.100 |
Why?
| | Exercise Test | 1 | 2014 | 137 | 0.100 |
Why?
| | Metabolome | 1 | 2015 | 107 | 0.100 |
Why?
| | Vitamin D Deficiency | 1 | 2014 | 46 | 0.100 |
Why?
| | Analysis of Variance | 1 | 2015 | 547 | 0.100 |
Why?
| | Vitamin D | 1 | 2014 | 91 | 0.100 |
Why?
| | Organ Size | 1 | 2014 | 226 | 0.100 |
Why?
| | Asthma | 1 | 2017 | 319 | 0.100 |
Why?
| | Metabolomics | 1 | 2015 | 155 | 0.100 |
Why?
| | Ibuprofen | 1 | 2013 | 24 | 0.100 |
Why?
| | Membrane Proteins | 1 | 2015 | 333 | 0.100 |
Why?
| | Nicotinamide Phosphoribosyltransferase | 1 | 2013 | 6 | 0.100 |
Why?
| | Tachycardia, Supraventricular | 1 | 2013 | 36 | 0.100 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2013 | 79 | 0.100 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2013 | 40 | 0.100 |
Why?
| | Voluntary Health Agencies | 1 | 2012 | 4 | 0.100 |
Why?
| | Heart Septal Defects, Atrial | 1 | 2013 | 45 | 0.100 |
Why?
| | Leukocyte Count | 1 | 2013 | 71 | 0.100 |
Why?
| | International Agencies | 1 | 2012 | 16 | 0.100 |
Why?
| | Adiponectin | 1 | 2013 | 47 | 0.100 |
Why?
| | Cardiovascular Agents | 1 | 2013 | 66 | 0.100 |
Why?
| | Absorptiometry, Photon | 1 | 2013 | 160 | 0.090 |
Why?
| | Central Nervous System Stimulants | 1 | 2014 | 201 | 0.090 |
Why?
| | Awareness | 1 | 2012 | 26 | 0.090 |
Why?
| | Anxiety | 1 | 2015 | 321 | 0.090 |
Why?
| | Fatty Acids | 1 | 2013 | 154 | 0.090 |
Why?
| | Multivariate Analysis | 3 | 2020 | 598 | 0.090 |
Why?
| | Catheter Ablation | 1 | 2013 | 125 | 0.090 |
Why?
| | Disease Management | 1 | 2013 | 187 | 0.090 |
Why?
| | Lipoproteins, LDL | 1 | 2013 | 175 | 0.090 |
Why?
| | Needs Assessment | 1 | 2012 | 145 | 0.090 |
Why?
| | Bone Morphogenetic Protein 4 | 1 | 2010 | 8 | 0.080 |
Why?
| | Kidney | 1 | 2015 | 715 | 0.080 |
Why?
| | Diet Surveys | 2 | 2022 | 33 | 0.080 |
Why?
| | Quercetin | 1 | 2009 | 18 | 0.080 |
Why?
| | Glutamate-Cysteine Ligase | 1 | 2009 | 20 | 0.080 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2009 | 41 | 0.080 |
Why?
| | Insulin-Secreting Cells | 1 | 2009 | 26 | 0.080 |
Why?
| | Early Growth Response Protein 1 | 1 | 2009 | 34 | 0.080 |
Why?
| | Puerto Rico | 2 | 2019 | 17 | 0.080 |
Why?
| | Actinomyces | 2 | 2019 | 12 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 502 | 0.080 |
Why?
| | Colonoscopy | 1 | 2009 | 107 | 0.070 |
Why?
| | Adenoma | 1 | 2009 | 114 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2014 | 815 | 0.070 |
Why?
| | Antioxidants | 1 | 2009 | 264 | 0.070 |
Why?
| | Valsalva Maneuver | 3 | 2013 | 10 | 0.060 |
Why?
| | Life Style | 2 | 2022 | 150 | 0.060 |
Why?
| | Parity | 1 | 2026 | 46 | 0.060 |
Why?
| | Posture | 3 | 2013 | 65 | 0.060 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 487 | 0.060 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2009 | 647 | 0.060 |
Why?
| | Forced Expiratory Volume | 1 | 2025 | 51 | 0.060 |
Why?
| | Respiratory Function Tests | 1 | 2025 | 89 | 0.060 |
Why?
| | Spirometry | 1 | 2025 | 33 | 0.060 |
Why?
| | Glomerular Filtration Rate | 2 | 2015 | 128 | 0.060 |
Why?
| | Cholesterol, LDL | 2 | 2016 | 42 | 0.060 |
Why?
| | Mastectomy | 1 | 2026 | 147 | 0.060 |
Why?
| | Vitamin B 12 | 2 | 2014 | 27 | 0.050 |
Why?
| | Air Pollution | 1 | 2025 | 49 | 0.050 |
Why?
| | Folic Acid | 2 | 2014 | 137 | 0.050 |
Why?
| | Patient Education as Topic | 1 | 2007 | 325 | 0.050 |
Why?
| | Iatrogenic Disease | 1 | 2023 | 26 | 0.050 |
Why?
| | Polysomnography | 1 | 2022 | 76 | 0.050 |
Why?
| | Poverty | 1 | 2024 | 233 | 0.050 |
Why?
| | Diet, Vegetarian | 1 | 2022 | 8 | 0.050 |
Why?
| | Thinness | 1 | 2022 | 44 | 0.050 |
Why?
| | Longevity | 1 | 2022 | 85 | 0.040 |
Why?
| | Disease Progression | 2 | 2018 | 880 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 96 | 0.040 |
Why?
| | Mortality | 1 | 2021 | 98 | 0.040 |
Why?
| | Regression Analysis | 2 | 2013 | 391 | 0.040 |
Why?
| | Echocardiography | 2 | 2013 | 409 | 0.040 |
Why?
| | Fatty Liver | 1 | 2021 | 145 | 0.040 |
Why?
| | Poultry | 1 | 2019 | 25 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2023 | 1219 | 0.040 |
Why?
| | Receptors, Progesterone | 1 | 2019 | 68 | 0.040 |
Why?
| | Receptor, erbB-2 | 1 | 2019 | 79 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2019 | 192 | 0.040 |
Why?
| | Reflex | 1 | 2018 | 30 | 0.040 |
Why?
| | Animals | 3 | 2022 | 13526 | 0.040 |
Why?
| | Public Health Surveillance | 1 | 2018 | 18 | 0.030 |
Why?
| | Biometry | 1 | 2017 | 18 | 0.030 |
Why?
| | Vaccination | 1 | 2020 | 310 | 0.030 |
Why?
| | DNA Methylation | 1 | 2022 | 592 | 0.030 |
Why?
| | Oral Hygiene | 1 | 2017 | 6 | 0.030 |
Why?
| | Dietary Carbohydrates | 1 | 2018 | 91 | 0.030 |
Why?
| | Piperidones | 1 | 2017 | 6 | 0.030 |
Why?
| | Sodium-Glucose Transporter 2 | 1 | 2017 | 22 | 0.030 |
Why?
| | Glucosides | 1 | 2017 | 21 | 0.030 |
Why?
| | Hemodynamics | 1 | 2018 | 236 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 659 | 0.030 |
Why?
| | Sleep Apnea Syndromes | 1 | 2017 | 34 | 0.030 |
Why?
| | Hyperlipidemias | 1 | 2017 | 52 | 0.030 |
Why?
| | Exhalation | 1 | 2016 | 20 | 0.030 |
Why?
| | Benzhydryl Compounds | 1 | 2017 | 70 | 0.030 |
Why?
| | Dyslipidemias | 1 | 2016 | 42 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2016 | 61 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2016 | 291 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2017 | 405 | 0.030 |
Why?
| | Pyrimidines | 1 | 2017 | 205 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2015 | 58 | 0.030 |
Why?
| | Hospitals, Teaching | 1 | 2015 | 52 | 0.030 |
Why?
| | Liver | 1 | 2021 | 1150 | 0.030 |
Why?
| | Intervertebral Disc Displacement | 1 | 2015 | 13 | 0.030 |
Why?
| | Proteinuria | 1 | 2015 | 38 | 0.030 |
Why?
| | Spinal Stenosis | 1 | 2015 | 12 | 0.030 |
Why?
| | Sulfonylurea Compounds | 1 | 2014 | 7 | 0.030 |
Why?
| | Recurrence | 1 | 2016 | 694 | 0.030 |
Why?
| | Eating | 1 | 2015 | 159 | 0.030 |
Why?
| | Macular Edema | 1 | 2015 | 31 | 0.030 |
Why?
| | Infant | 2 | 2013 | 3805 | 0.030 |
Why?
| | Immunoassay | 1 | 2014 | 23 | 0.030 |
Why?
| | Child, Preschool | 2 | 2013 | 4162 | 0.030 |
Why?
| | Refraction, Ocular | 1 | 2014 | 7 | 0.030 |
Why?
| | Population Surveillance | 1 | 2015 | 164 | 0.030 |
Why?
| | Area Under Curve | 1 | 2014 | 185 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 2015 | 101 | 0.030 |
Why?
| | Patients | 1 | 2014 | 52 | 0.030 |
Why?
| | Chemical Phenomena | 1 | 2013 | 13 | 0.020 |
Why?
| | Taurine | 1 | 2013 | 18 | 0.020 |
Why?
| | Particle Size | 1 | 2013 | 76 | 0.020 |
Why?
| | Progesterone | 1 | 2013 | 57 | 0.020 |
Why?
| | Brain | 1 | 2021 | 1350 | 0.020 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 124 | 0.020 |
Why?
| | Atherosclerosis | 1 | 2014 | 224 | 0.020 |
Why?
| | Lipoproteins, HDL | 1 | 2011 | 16 | 0.020 |
Why?
| | Sp1 Transcription Factor | 1 | 2009 | 20 | 0.020 |
Why?
| | Diastole | 1 | 2010 | 66 | 0.020 |
Why?
| | Systole | 1 | 2010 | 71 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2009 | 64 | 0.020 |
Why?
| | Adiposity | 1 | 2010 | 147 | 0.020 |
Why?
| | Colonic Polyps | 1 | 2009 | 39 | 0.020 |
Why?
| | Creatinine | 1 | 2008 | 158 | 0.020 |
Why?
| | Time | 1 | 2007 | 28 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2009 | 1133 | 0.020 |
Why?
| | Self Care | 1 | 2007 | 136 | 0.010 |
Why?
| | Rats | 1 | 2009 | 3162 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2013 | 5595 | 0.010 |
Why?
| | Hospitalization | 1 | 2007 | 749 | 0.010 |
Why?
|
|
Park's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|